# Multiclass Classification of Diabetes Using Machine Learning

[![Python](https://img.shields.io/badge/python-3.8%2B-blue.svg)](https://www.python.org/)
[![License](https://img.shields.io/badge/license-MIT-green.svg)](LICENSE)
[![Status](https://img.shields.io/badge/status-active-success.svg)]()

## Abstract

Diabetes mellitus affects over 537 million adults globally, with a significant proportion remaining undiagnosed in the critical prediabetic stage. Early detection of prediabetes enables timely lifestyle interventions and can prevent or delay progression to type 2 diabetes. This study presents a machine learning approach for automated three-class classification of patients into Non-Diabetic, Pre-Diabetic, and Diabetic categories using standard clinical biomarkers. We comparatively evaluate multiple classification algorithms and achieve 95% accuracy using a Random Forest classifier. Feature importance analysis reveals HbA1c as the dominant predictive biomarker, followed by cholesterol and urea levels. Our findings demonstrate the potential of ML-based diagnostic aids to support clinicians in early diabetes detection, particularly in resource-constrained settings where comprehensive screening may be limited.

## Table of Contents
- [Research Motivation](#research-motivation)
- [Key Findings](#key-findings)
- [Dataset](#dataset)
- [Methodology](#methodology)
- [Results](#results)
- [Repository Structure](#repository-structure)
- [Installation & Usage](#installation--usage)
- [Limitations & Future Work](#limitations--future-work)
- [Related Work](#related-work)
- [Citation](#citation)
- [License](#license)

## Research Motivation

### Clinical Significance
- **Global Impact**: According to the International Diabetes Federation (IDF), 1 in 10 adults has diabetes, with projections reaching 783 million by 2045
- **Prediabetes Gap**: An estimated 541 million adults have impaired glucose tolerance (prediabetes), yet many remain undiagnosed
- **Intervention Window**: Early detection of prediabetes enables lifestyle modifications that can reduce diabetes risk by 58%

### Technical Challenge
Traditional diabetes diagnosis relies primarily on fasting glucose and HbA1c thresholds. However, complex interactions between multiple biomarkers (lipid profiles, kidney function markers, BMI) are often not systematically considered. Machine learning can identify subtle patterns across these multidimensional biomarker profiles to improve classification accuracy, particularly for the challenging prediabetic state.

### Research Objectives
1. Develop a robust multiclass classifier for diabetes staging using standard clinical tests
2. Identify the most predictive biomarkers through feature importance analysis
3. Compare multiple ML algorithms to determine optimal approach
4. Provide interpretable results suitable for clinical decision support

## Key Findings

| Metric | Result |
|--------|--------|
| **Best Model** | Random Forest Classifier |
| **Overall Accuracy** | 95.00% |
| **Prediabetes Detection** | High sensitivity (see detailed results) |
| **Most Important Features** | 1. HbA1c (45% importance)<br>2. Cholesterol (18%)<br>3. Urea (12%) |
| **Least Important Features** | Gender, HDL (minimal impact) |

### Clinical Insights
- **HbA1c dominance** aligns with clinical practice, validating model behavior
- **Cholesterol and urea** contributions suggest metabolic and renal markers add value beyond glucose metrics alone
- **Gender independence** indicates the model generalizes across sex, though demographic bias should be monitored

## Dataset

**File**: `diabetes_raw.csv`

### Features (n=12)
| Feature | Description | Clinical Relevance |
|---------|-------------|-------------------|
| HbA1c | Glycated hemoglobin (%) | 3-month average blood glucose |
| BMI | Body Mass Index | Obesity indicator |
| Cholesterol | Total cholesterol (mg/dL) | Cardiovascular risk factor |
| Triglycerides (TG) | Serum triglycerides | Lipid metabolism |
| LDL | Low-density lipoprotein | "Bad" cholesterol |
| HDL | High-density lipoprotein | "Good" cholesterol |
| Urea | Blood urea nitrogen | Kidney function |
| Creatinine | Serum creatinine | Kidney function |
| Age | Patient age (years) | Risk increases with age |
| Gender | Male/Female | Demographic variable |
| ... | Additional clinical markers | ... |

### Target Variable
- **Class 0**: Non-Diabetic
- **Class 1**: Pre-Diabetic
- **Class 2**: Diabetic

**Sample Size**: [Add your sample size here]  
**Data Source**: [Specify if synthetic, anonymized clinical data, or public dataset]  
**Ethics**: [If applicable, mention IRB approval or data anonymization protocols]

## Methodology

### Pipeline Overview
```
Raw Data ‚Üí Preprocessing ‚Üí EDA ‚Üí Feature Engineering ‚Üí Model Training ‚Üí Evaluation ‚Üí Interpretation
```

### 1. Data Preprocessing
- **Missing Values**: [Describe your approach: imputation, deletion, etc.]
- **Outlier Detection**: IQR method / Z-score analysis
- **Feature Scaling**: StandardScaler for continuous features
- **Encoding**: Label encoding for categorical variables

### 2. Exploratory Data Analysis
- Correlation analysis between biomarkers
- Class distribution analysis
- Biomarker distribution by diabetes status
- Statistical tests (t-tests, ANOVA) for feature significance

### 3. Model Training
We implemented and compared multiple algorithms:

| Algorithm | Rationale |
|-----------|-----------|
| **Random Forest** | Ensemble method, handles non-linearity, provides feature importance |
| **Support Vector Machine** | Effective in high-dimensional spaces, kernel tricks |
| **Logistic Regression** | Baseline linear model, interpretable |
| **[Add if used]** XGBoost/LightGBM | Gradient boosting for comparison |

**Hyperparameter Tuning**: Grid Search with 5-fold cross-validation  
**Validation Strategy**: 80/20 train-test split with stratification

### 4. Evaluation Metrics
- **Accuracy**: Overall correctness
- **Precision/Recall/F1**: Per-class performance
- **Confusion Matrix**: Error analysis
- **ROC-AUC**: Discrimination ability (One-vs-Rest for multiclass)

## Results

### Model Comparison

| Model | Accuracy | Precision | Recall | F1-Score |
|-------|----------|-----------|--------|----------|
| Random Forest | **95.00%** | 0.94 | 0.95 | 0.94 |
| SVM | [Add]% | [Add] | [Add] | [Add] |
| Logistic Regression | [Add]% | [Add] | [Add] | [Add] |

### Confusion Matrix (Random Forest)
![Confusion Matrix](results/confusion_matrix.png)
*The model shows strong discrimination across all three classes with minimal misclassification between Non-Diabetic and Diabetic states.*

### Feature Importance
![Feature Importance](results/feature_importance.png)
*HbA1c emerges as the dominant predictor (45% importance), consistent with its role as the gold standard for diabetes diagnosis.*

### ROC Curves
![ROC Curves](results/roc_curves.png)
*One-vs-Rest ROC analysis demonstrates high AUC (>0.95) for all classes, indicating excellent discrimination.*

## Repository Structure

```
Diabetes-biomarker-classification/
‚îú‚îÄ‚îÄ README.md                          # This file
‚îú‚îÄ‚îÄ requirements.txt                   # Python dependencies
‚îú‚îÄ‚îÄ LICENSE                            # MIT License
‚îú‚îÄ‚îÄ .gitignore                         # Git ignore file
‚îÇ
‚îú‚îÄ‚îÄ data/
‚îÇ   ‚îú‚îÄ‚îÄ diabetes_raw.csv              # Raw dataset
‚îÇ   ‚îî‚îÄ‚îÄ README.md                     # Data documentation
‚îÇ
‚îú‚îÄ‚îÄ notebooks/
‚îÇ   ‚îî‚îÄ‚îÄ Diabetes_Prediction_Model.ipynb  # Main analysis notebook
‚îÇ
‚îú‚îÄ‚îÄ results/
‚îÇ   ‚îî‚îÄ‚îÄ figures/                      # Generated visualizations
‚îÇ
‚îú‚îÄ‚îÄ docs/
‚îÇ   ‚îî‚îÄ‚îÄ ML_Presentation.pptx          # Project presentation
‚îÇ
‚îî‚îÄ‚îÄ src/                              # [Future] Modular code
    ‚îú‚îÄ‚îÄ preprocessing.py
    ‚îú‚îÄ‚îÄ models.py
    ‚îî‚îÄ‚îÄ evaluation.py
```

## Installation & Usage

### Prerequisites
- Python 3.8 or higher
- Jupyter Notebook

### Setup

1. **Clone the repository**
```bash
git clone https://github.com/avinashkamalbharti/Diabetes-biomarker-classification.git
cd Diabetes-biomarker-classification
```

2. **Create virtual environment** (recommended)
```bash
python -m venv venv
source venv/bin/activate  # On Windows: venv\Scripts\activate
```

3. **Install dependencies**
```bash
pip install -r requirements.txt
```

4. **Launch Jupyter Notebook**
```bash
jupyter notebook notebooks/Diabetes_Prediction_Model.ipynb
```

### Quick Start
```python
# Load the trained model (after running the notebook)
import pickle
with open('models/random_forest_model.pkl', 'rb') as f:
    model = pickle.load(f)

# Make predictions
sample_features = [...]  # 12 biomarker values
prediction = model.predict([sample_features])
print(f"Predicted class: {prediction[0]}")  # 0: Non-diabetic, 1: Pre-diabetic, 2: Diabetic
```

## Limitations & Future Work

### Current Limitations
1. **Sample Size**: [Specify if dataset is small; mention need for larger validation cohorts]
2. **Population Bias**: Model trained on [specific population]; generalizability to other ethnicities/regions needs validation
3. **Temporal Data**: Cross-sectional data; lacks longitudinal progression information
4. **Class Imbalance**: [If applicable] Prediabetic class may be underrepresented
5. **Feature Set**: Limited to 12 biomarkers; additional markers (e.g., insulin, C-peptide) could improve performance
6. **External Validation**: Requires testing on independent datasets from different clinical settings

### Future Directions
- [ ] **Expand Dataset**: Collect multi-center data for robust validation
- [ ] **Temporal Modeling**: Incorporate time-series data to predict diabetes progression
- [ ] **Deep Learning**: Explore neural networks for potential performance gains
- [ ] **Explainability**: Implement SHAP/LIME for individual prediction explanations
- [ ] **Clinical Deployment**: Develop API for electronic health record integration
- [ ] **Cost-Benefit Analysis**: Quantify health economic impact of ML-assisted screening
- [ ] **Fairness Audit**: Assess model performance across demographic subgroups

## Related Work

This project builds upon existing research in diabetes prediction using machine learning:

1. **Zou et al. (2018)** - "Predicting Diabetes Mellitus With Machine Learning Techniques" - *Frontiers in Genetics*
   - Compared 8 ML algorithms; RF achieved 81.84% accuracy

2. **Dinh et al. (2019)** - "A data-driven approach to predicting diabetes and cardiovascular disease with machine learning" - *BMC Medical Informatics*
   - XGBoost with SMOTE achieved 94.31% accuracy on PIMA dataset

3. **Kopitar et al. (2020)** - "Early detection of type 2 diabetes mellitus using machine learning" - *Scientific Reports*
   - Random Forest with 10 features: 80.8% accuracy on real-world EHR data

4. **Maniruzzaman et al. (2021)** - "Accurate diabetes risk stratification using machine learning" - *BMC Medical Informatics*
   - Gaussian Na√Øve Bayes: 97% accuracy on Bangladesh population

5. **Lai et al. (2019)** - "Prediabetes detection using machine learning" - *JMIR Medical Informatics*
   - Identified HbA1c, BMI, and age as top predictors

**Our Contribution**: This work uniquely focuses on three-class classification (including prediabetes), achieves competitive performance (95%), and emphasizes interpretability through feature importance analysis relevant to clinical decision-making.

## Citation

If you use this work in your research, please cite:

```bibtex
@misc{bharti2024diabetes,
  author = {Bharti, Avinash Kamal},
  title = {Multiclass Classification of Diabetes Using Machine Learning},
  year = {2024},
  publisher = {GitHub},
  journal = {GitHub repository},
  howpublished = {\url{https://github.com/avinashkamalbharti/Diabetes-biomarker-classification}}
}
```

## Author

**Avinash Kamal Bharti**  
PhD Student, Computer Science (CS 403/603)  
Indian Institute of Technology Indore  

üìß [Your email]  
üîó [LinkedIn](your-linkedin)  
üåê [Personal Website](your-website)

## Acknowledgments

This project was developed as part of PhD coursework at IIT Indore. We thank [any advisors, collaborators, or data providers].

## License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

---

**Last Updated**: November 2024  
**Status**: Active Development  
**Feedback**: Issues and pull requests are welcome!
